CERS’ INTERCEPT platform (kits + illuminators) is scaling globally, with record 2025 results. They’ve also grown their ...

An informational report analyzing HaloGrow Hair Spray search queries in 2026, including ingredient research context, ...

Today, in the second part of this unmissable series, we'll see how making changes to our daily food choices and sleeping ...

As we inch towards spring, we won't let you miss these fresh deals.

BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported 2025 results with revenues of ...

Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...